Skip to main content
Log in

The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer

  • Original Paper
  • Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

A series of 191 female breast carcinomas (with long-term follow-up) were analysed immunohistochemically (with a monoclonal MIB1 antibody) for Ki-67 (a proliferation marker) expression with special reference to well-established prognostic factors and patient survival. Expression of Ki-67 was directly related to the S-phase fraction (P<0.0001), the volume-corrected mitotic index (P<0.0001), histological grade (P<0.0001), the apoptotic index (P<0.0001), oestrogen and progesterose receptor content (P<0.0001 for both) and p53 accumulation (P=0.001). No correlation was found between Ki-67 expression and lymph node status (P=0.25), metastasis at operation (n=0.81) or tumour size (n=0.38). The proliferation rate, as measured by image analysis of Ki-67 expression, predicted survival in the entire cohort (P=0.001) and in axillary-lymph-node-negative (ANN) patients (P=0.003). The difference in recurrence-free survival between the high- and low-expression groups was greatest in ANN tumours, 40% (P=0.008). In axillary-lymph-node-positive tumours, the Ki-67 expression was not significantly related to recurrence-free survival (P=0.723). The results of multivariate survival analysis showed that tumour size, axillary lymph node status, and mitotic index were independent prognostic factors in the entire series whereas, in ANN cases, tumour size and Ki-67 labelling were independent prognostic factors. These findings imply that Ki-67 expression could be an important prognostic determinant in breast cancer. Because of the evident loss of the predictive power of tumour size in the 1990s, the prognostic value of Ki-67 expression may even be accentuated in the currently diagnosed small breast carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

M/V :

index the volume-corrected mitotic index

ANN :

axillary lymph node negative

ANP :

axillary lymph node positive

References

  • Aaltomaa S, Lipponen P, Eskelimen M, Kosma VM, Marin S, Alhava E, Syrjanen K (1991) Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer. Int J Cancer 49:886–892

    PubMed  Google Scholar 

  • Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E Syrjanen K (1992) Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol 118:75–81

    PubMed  Google Scholar 

  • Beck T, Weller EE, Brumm C, Wilkens C, Knapstein PG (1995) Usefullness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognostic parameters and with the proliferation marker, MIB-1. Gynecol Oncol 57:96–104.

    PubMed  Google Scholar 

  • Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359–377

    PubMed  Google Scholar 

  • Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JF, Blamey RW, Nicholson RI (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59:943–947

    PubMed  Google Scholar 

  • Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489–503

    Google Scholar 

  • Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen(MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363

    PubMed  Google Scholar 

  • Chauvel P, Courdi A, Gioanni J, Vallicinoi J, Santini J, Demard F (1989) The labelling index: a prognostic factor in head and neck carcinoma. Radiother Oncol 14:231–237

    PubMed  Google Scholar 

  • Eskelinen M, Lipponen P, Papinaho S, Aaltomaa S, Kosma VM, Klemi P, Syrjanen K (1992) DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 51:555–561

    PubMed  Google Scholar 

  • Gasparini G, Boracchi P, Verderio P, Bevilacqua P (1994) Cell kinetics in human brest cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 57:822–829

    PubMed  Google Scholar 

  • Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501

    PubMed  Google Scholar 

  • Huovinen R, Collany (1994) Cell loss in dimethylbenz(a)anthraceneinduced rat mammary carcinoma treated with toremifene and ovariectomy. Tumor Biol 15:345–353

    Google Scholar 

  • Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumour suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109–1114

    PubMed  Google Scholar 

  • Jensen EV (1991) Steroid hormone receptors. Curr Top Pathol 83:365–431

    PubMed  Google Scholar 

  • Kennedy JC, Badawy N, el, DeRose PB, Cohen C (1992) Comparison of cell prolifration in breast carcinoma using image analysis (Ki-67) and flow cytometric systems. Anal Quant Cytol Histol 14:304–311

    PubMed  Google Scholar 

  • Kerr JF, Winterford CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013–2026

    PubMed  Google Scholar 

  • Lee E, Lesu M (1972) A computer program for comparing k samples with right censored data. Comput Prog Biomed 2:315–320

    Google Scholar 

  • Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266:54–59, 62–63

    Google Scholar 

  • Martinazzi M, Crivelli F, Zampatti C, Martinazzi S (1993) Relationship between p53 expression and other progonostic factors in human breast carcinoma. An immunohistochemical study. Am J Clin Pathol 100:213–217

    PubMed  Google Scholar 

  • Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA Preisler HD (1992)c-myc, c-erb B-2, and Ki-67 expression in normal breast tissue and in invasive and noninvassive breast carcinoma. Cancer Res 52:2597–2602

    PubMed  Google Scholar 

  • Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K (1995) Expression of p53 protein has no independent prognostic value in breast cancer. J Pathol 177:225–232

    PubMed  Google Scholar 

  • Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW Ellis IO (1995) Assessment of the new proliferation marker MIBI in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 71:146–149

    PubMed  Google Scholar 

  • Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllonen L, von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68:579–583

    PubMed  Google Scholar 

  • Rudas M, Gnant MF, Mittlbock M, Neumayer R, Kummer A, Jakesz R, Reiner G, Reiner A (1994) Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis. Breast Cancer Res Treat 32:165–175

    PubMed  Google Scholar 

  • Schulte Hermann R, Grasl Kraupp B, Bursch W (1994) Tumour development and apoptosis. Int Arch Allergy Immunol 105:363–367

    PubMed  Google Scholar 

  • Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U (1993) p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965–970

    PubMed  Google Scholar 

  • Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1145–1449

    Google Scholar 

  • Vihko R, Jänne O, Kontula K, Syrjälä P (1980) Female sex steroid reseptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels. Int J Can 26:13–21

    Google Scholar 

  • Walker NI, Harmon BV, Gobe GC, Kerr JFR (1988) Patterns of cell death. Methods Achiev Exp Pathol 13:18–54

    PubMed  Google Scholar 

  • Weinder N, Moore DHI, Vartarian R (1994) Correlation of Ki-67 antigen expression with mitotic figure index and tumour grade in breast carcinoma using the novel “paraffin”-reactive MIBI antibody. Hum Pathol 25:337–342

    PubMed  Google Scholar 

  • WHO (1981) Histological typing of breast tumours. In: International histological classification of tumours. 2, 2nd ed. World Health Organization, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pietiläinen, T., Lipponen, P., Aaltomaa, S. et al. The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin Oncol 122, 687–692 (1996). https://doi.org/10.1007/BF01209033

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01209033

Key words

Navigation